Date: 04/14/2015
Final
Presentation on New Treatments for Hepatitis C
HOUSE COMMITTEE ON PUBLIC HEALTH CARE & HUMAN SERVICES
| Votes: View--> | Action Taken: |
| <none> | <none> |
01:36 PM -- Presentation on New Treatments for Hepatitis C
Nancy Steinfurth, Hepatitis C Connection, began the presentation on new treatments for Hepatitis C. She discussed the costs of medical treatment for individuals with Hepatitis C, and stated treatments approved by the federal Food and Drug Administration in 2013 and 2014 provide 95 percent effectiveness in curing Hepatitis C. She discussed the differences in the treatment protocol in 2010 to the current treatment protocol. She discussed the overall cost of treatments for Hepatitis C, and discussed the co-morbidities that may develop in individuals with Hepatitis C. She noted that the treatment drugs are classified as "tier 4 specialty" drugs under the Affordable Care Act, which means that patients pay a coinsurance, rather than a copayment, for the drugs. She discussed the coverage of the drugs by Medicaid. Ms. Steinfurth responded to questions from the committee.
01:47 PM
The committee recessed briefly.